Li Rui-Fang, Lou Jin-Xian, Zhang Tian-Yuan
School of Life Sciences, Key Laboratory of Genetic Engineering of Ministry of Education, Zhongshan University, Guangzhou 510275, China.
Sheng Wu Gong Cheng Xue Bao. 2004 Mar;20(2):274-8.
Chromogranin A (CGA) is a soluble protein existed in most secreted cells and neurons. It was recently found that the bovine CGA N terminal region has vasoinhibitory, antibacterial and antifungal activities. Since the need for effective antifungal agents increases in parallel with the expanding number of immunocompromised patients at risk for fungal infections, it becomes imperative to find antifungal compounds with low toxicity toward mammalian cells. To study the antifungal activity of CGA N terminal region, the DNA fragment encoding for the N terminal 1-76 amino acid sequence (CGA1-76) of human CGA was amplified by PCR technique. After DNA sequence analysis, the amplified DNA fragment was cloned into the Bacillus subtilis inducible and expression vector pSBPTQ constructed in this study and the resultant plasmid pSVTQ was then transformed into triple-protease deficient Bacillus subtilis strain DB403 competent cells. The transformants was screened on LB plates containing 10 microg/mL kanamycin. The positive transformant DB403 (pSVTQ) was grown on kanmycin containing 2 x MSR medium and sucrose was added to 2% final concentration for induction after 2h cultivation. The culture supernatant was used to run SDS-PAGE. The result of SDS-PAGE showed that the CGA1-76 was expressed by sucrose induction and the expressed product secreted into the medium with a yield of 5 mg/L. The expressed product reacts specifically with mouse anti CGA47-68 monoclonal antibody. The antifungal activity of the expressed product was examined by adding the culture supernatant to the fungal spore or Candida albican suspensions at appropriate proportion and found that the recombinant human CGA1-76 produced in Bacillus subtilis inhibits the growth of Fusarium sp. Alternaria sp. and Candida albican at the concerntration of 4 micromol/L. These results demonstrate that human CGA1-76 has expressed in Bacillus subtilis and the expressed product is immunogenic and has the antifungal activity.
嗜铬粒蛋白A(CGA)是一种存在于大多数分泌细胞和神经元中的可溶性蛋白质。最近发现,牛CGA的N端区域具有血管抑制、抗菌和抗真菌活性。由于随着有真菌感染风险的免疫功能低下患者数量的增加,对有效抗真菌剂的需求也随之增加,因此寻找对哺乳动物细胞毒性低的抗真菌化合物变得势在必行。为了研究CGA N端区域的抗真菌活性,通过PCR技术扩增了编码人CGA N端1-76个氨基酸序列(CGA1-76)的DNA片段。经过DNA序列分析后,将扩增的DNA片段克隆到本研究构建的枯草芽孢杆菌诱导表达载体pSBPTQ中,然后将所得质粒pSVTQ转化到三重蛋白酶缺陷型枯草芽孢杆菌菌株DB403感受态细胞中。在含有10μg/mL卡那霉素的LB平板上筛选转化子。阳性转化子DB403(pSVTQ)在含有2×MSR培养基的卡那霉素上生长,培养2小时后加入蔗糖至终浓度2%进行诱导。培养上清用于进行SDS-PAGE。SDS-PAGE结果表明,CGA1-76通过蔗糖诱导表达,表达产物分泌到培养基中,产量为5mg/L。表达产物与小鼠抗CGA47-68单克隆抗体发生特异性反应。通过将培养上清以适当比例加入真菌孢子或白色念珠菌悬液中来检测表达产物的抗真菌活性,发现枯草芽孢杆菌中产生的重组人CGA1-76在4μmol/L的浓度下抑制镰刀菌属、链格孢属和白色念珠菌的生长。这些结果表明,人CGA1-76已在枯草芽孢杆菌中表达,表达产物具有免疫原性并具有抗真菌活性。